Fortis Healthcare Limited (NSE:FORTIS)
India · Delayed Price · Currency is INR 961.95
-4.65 (-0.48%)
May 27, 2026, 3:30 PM IST
Fortis Healthcare Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Fortis Healthcare stock has a consensus rating of "Buy" and an average price target of ₹1,090. The average 1-year stock price forecast is 13.36% higher than the current stock price, while the lowest is ₹950.00 (-1.24%) and the highest is ₹1,192 (+23.91%).
Price Target: ₹1,090 (+13.36%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 28, 2026.
Analyst Ratings
The average analyst rating for Fortis Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 12 | 12 | 13 | 13 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 17 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Axis Direct No rating | Axis Direct | Buy Maintains ₹1,070 → ₹1,038 | Buy | Maintains | ₹1,070 → ₹1,038 | +7.91% | Feb 28, 2026 |
Unknown Analyst Prabhudas Lilladher No rating | Prabhudas Lilladher | Buy Maintains ₹1,050 | Buy | Maintains | ₹1,050 | +9.15% | Feb 18, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Downgrades ₹965.00 | Hold | Downgrades | ₹965.00 | +0.32% | Dec 7, 2025 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.